BlackRock ESG Capital Allocation Term Trust Defends Board Against Activist Saba Capital in Proxy Battle

summarizeSummary

BlackRock ESG Capital Allocation Term Trust (ECAT) has filed additional proxy materials, urging shareholders to support its current board and reject activist Saba Capital Management's nominees.

check_boxKey Events

• Board Defense in Proxy Battle

  ECAT's independent Board is actively campaigning to retain its current members, arguing that 'Change is NOT warranted' amidst the ongoing proxy contest with Saba Capital Management. This follows multiple proxy filings from both sides since February 2026.

• Highlights Superior Performance

  The filing emphasizes ECAT's 'superior shareholder returns,' 'higher yield on net asset value,' 'narrower discount,' and 'lower expense ratio' compared to its peers, presenting data up to April 30, 2026.

• Accuses Activist of Selling Shares

  ECAT explicitly states that Saba Capital Management has been 'aggressively selling ECAT' shares, representing a meaningful share of trading volume, while simultaneously seeking to take over the Board.

• Details Board Qualifications and Governance

  The company outlines the comprehensive skills and independence of its current board members and details rigorous governance and oversight practices, including discount management programs and shareholder engagement.

auto_awesomeAnalysis

This filing is a critical communication from BlackRock ESG Capital Allocation Term Trust (ECAT) to shareholders, part of an intense and ongoing proxy battle with activist investor Saba Capital Management. The company is actively soliciting votes to retain its current board, presenting arguments and performance data to counter Saba's nominations. The outcome of this board election will significantly impact the fund's future governance and strategy.